Skip to main content

Table 2 Patient characteristics

From: The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility

Variable

Baseline value (N = 204)

Age, years, mean (SD)

70.5 (10.9)

Sex, n (%)

 Male

138 (67.6)

 Female

66 (32.4)

Type of MI, n (%)

 NSTEMI

127 (62.3)

 STEMI

77 (37.7)

SPM, n (%)

 Aspirin

190 (93.1)

 Other antiplatelet agent

192 (94.1)

 Ticagrelor (twice daily)

159 (77.9)

 ACE inhibitor / ARB

188 (92.2)

  Twice daily dosing

44 (21.6)

 Beta-blocker

180 (88.2)

  Twice daily dosing

23 (11.3)

 Statin

192 (94.1)

SPM administration times,* n (%)

 One regular administration time per day

5 (2.5)

 Two regular administration times per day

147 (72.1)

 Three regular administration times per day

40 (19.6)

 Not completed

12 (5.9)

  1. N = 204. *The total number of times the patient had to take a medicine, regardless of the number of medicines taken at the point of administration (i.e. more than one medicine may have been taken at each administration time). ACE Angiotensin converting enzyme, ARB Angiotensin II receptor blocker, NSTEMI non-ST-elevation myocardial infarction, MI Myocardial infarction, SD Standard deviation, SPM Secondary prevention medicine, STEMI ST-elevation myocardial infarction